484 related articles for article (PubMed ID: 24118881)
1. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
Tao L; Shi B; Shi G; Wan H
Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
Compalati E; Passalacqua G; Bonini M; Canonica GW
Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis.
Olaguíbel JM; Alvarez Puebla MJ
J Investig Allergol Clin Immunol; 2005; 15(1):9-16. PubMed ID: 15864877
[TBL] [Abstract][Full Text] [Related]
5. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
6. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
8. [A Meta-analysis of efficacy and safety of sublingual immunotherapy on allergic asthma].
Wu YY; Xie XM; Han D; Li SJ; Liu L; Li MX
Zhonghua Nei Ke Za Zhi; 2013 Oct; 52(10):844-8. PubMed ID: 24378062
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
11. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani R; Huerta J; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):141-8. PubMed ID: 16937742
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir.
Baba SM; Rasool R; Gull A; Qureshi TA; Beigh AH; Qadri Q; Shah ZA
Front Immunol; 2021; 12():723814. PubMed ID: 34721385
[TBL] [Abstract][Full Text] [Related]
18. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.
Penagos M; Passalacqua G; Compalati E; Baena-Cagnani CE; Orozco S; Pedroza A; Canonica GW
Chest; 2008 Mar; 133(3):599-609. PubMed ID: 17951626
[TBL] [Abstract][Full Text] [Related]
19. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses.
Compalati E; Penagos M; Tarantini F; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):22-8. PubMed ID: 19205281
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: A meta-analysis of randomized controlled trials.
Feng B; Wu J; Chen B; Xiang H; Chen R; Li B; Chen S
Am J Rhinol Allergy; 2017 Jan; 31(1):27-35. PubMed ID: 28234149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]